Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Equity (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Return on Equity for 8 consecutive years, with 0.11% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 9.0% year-over-year to 0.11%, compared with a TTM value of 0.11% through Sep 2025, up 9.0%, and an annual FY2024 reading of 0.02%, up 59.0% over the prior year.
  • Return on Equity was 0.11% for Q3 2025 at Bicycle Therapeutics, down from 0.09% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.01% in Q4 2024 and bottomed at 0.6% in Q2 2023.
  • Average Return on Equity over 5 years is 0.32%, with a median of 0.34% recorded in 2022.
  • The sharpest move saw Return on Equity crashed -43bps in 2021, then soared 48bps in 2024.
  • Year by year, Return on Equity stood at 0.26% in 2021, then crashed by -53bps to 0.4% in 2022, then decreased by -16bps to 0.47% in 2023, then surged by 103bps to 0.01% in 2024, then crashed by -943bps to 0.11% in 2025.
  • Business Quant data shows Return on Equity for BCYC at 0.11% in Q3 2025, 0.09% in Q2 2025, and 0.03% in Q1 2025.